MIF is an important microenvironmental factor in glioma, and we previously identified an immune-suppressive pathway in GBM that is driven by secreted MIF from cancer stem cells (CSCs) that in turn activates myeloid-derived suppressor cells (MDSCs) (21). Here, MIF is linked to glioma.